SEC Form 4 · accession 0001209191-15-077556
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey L Edwards
Director
Period of report
Oct 28, 2015
Accepted (ET)
Oct 30, 2015 · 7:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $24.77 | Oct 28, 2015 | A | 12,000 | A | — | Oct 28, 2025 | Common Stock | 12,000 | 12,000 | D |
| Stock Option (Right to Buy)F2,F3 | $24.77 | Oct 28, 2015 | A | 7,168 | A | — | Oct 28, 2025 | Common Stock | 7,168 | 7,168 | D |
Explanation of responses
- F1Option vests quarterly over three years from October 28, 2015.
- F2Not applicable.
- F3Option vests as to 1,168 shares on 12/3/2015, 3,000 shares on 3/3/16 and 3,000 shares on 6/3/16.